NDC 57664-265 - Atenolol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 57664-265
- Package NDCs from labels
- 57664-265-88, 57664-265-13, 57664-265-18
- Manufacturer
- CARACO PHARMACEUTICAL LABORATORIES, LTD.
- Effective date
- 2007-07-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Atenolol - CARACO PHARMACEUTICAL LABORATORIES, LTD. | CARACO PHARMACEUTICAL LABORATORIES, LTD. | 2007-07-10 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 57664-265-13 | Atenolol | 500 in 1 BOTTLE | TABLET | 500 | 1 | |
| 57664-265-18 | Atenolol | 1000 in 1 BOTTLE | TABLET | 1000 | 1 | |
| 57664-265-88 | Atenolol | 100 in 1 BOTTLE | TABLET | 100 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 57664-265-18 | EA - Each | 57664-265 | 0c053fdb-3d4b-49a6-acd9-1eb2f1948928 | 1 | 2013-02-13 |
| 57664-265-88 | EA - Each | 57664-265 | 6b08e501-9a83-4ab8-bb66-b09c8b1e3d20 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| atenolol | ATENOLOL | direct rx | b3c757de-1cbf-61f5-e053-2995a90accfc | 2026-03-06 | Boxed warning, Warnings, Adverse reactions | 197379 |
| Atenolol | ATENOLOL | A-S Medication Solutions | b6fe1a12-a6d5-4c4c-9d77-6f717b43f8fe | 2026-02-20 | Boxed warning, Warnings, Adverse reactions | 197381 |
| Atenolol | ATENOLOL | A-S Medication Solutions | d21f2b4d-6584-48e5-8045-e5927ba03329 | 2026-02-20 | Boxed warning, Warnings, Adverse reactions | 197381 |
| Atenolol | ATENOLOL | Mylan Pharmaceuticals Inc. | a7048c81-6769-436b-8397-fbaa7489fcdf | 2026-02-15 | Warnings, Adverse reactions | 197379 197380 197381 |
| Atenolol | ATENOLOL | A-S Medication Solutions | d7a93c64-0c52-4d72-a9be-37c7ca355cdf | 2026-02-04 | Warnings, Adverse reactions | 197379 |
| Atenolol | ATENOLOL | Ipca Laboratories Limited | 98d29958-b026-4888-a516-7bb85bb7d479 | 2026-01-21 | Boxed warning, Warnings, Adverse reactions | 197379 197380 197381 |
| Atenolol | ATENOLOL | A-S Medication Solutions | 43acd912-f0f4-47eb-b81f-cbbfed77c557 | 2026-01-06 | Boxed warning, Warnings, Adverse reactions | 197381 |
| Atenolol | ATENOLOL | A-S Medication Solutions | e4ece8f4-3714-42ba-b36d-d00586dfd33a | 2026-01-06 | Boxed warning, Warnings, Adverse reactions | 197381 |
| Atenolol | ATENOLOL | Northwind Health Company, LLC | f31b11ed-2ff6-5cfc-e053-2a95a90af2ca | 2026-01-01 | Warnings, Adverse reactions | 197380 |
| Atenolol | ATENOLOL | Northwind Health Company, LLC | f318707a-4fb9-604c-e053-2a95a90ae973 | 2026-01-01 | Warnings, Adverse reactions | 197380 |
| Atenolol | ATENOLOL | Northwind Health Company, LLC | f76d03b8-f8d6-59b8-e053-6394a90a3a3f | 2026-01-01 | Warnings, Adverse reactions | 197381 |
| Atenolol | ATENOLOL | Northwind Health Company, LLC | db5bd8e2-1314-0f7f-e053-2995a90ae86e | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 197380 |
| Atenolol | ATENOLOL | Northwind Health Company, LLC | d9cdc2ed-99bf-0d6a-e053-2a95a90a0262 | 2026-01-01 | Warnings, Adverse reactions | 197379 |
| Atenolol | ATENOLOL | Northwind Health Company, LLC | f2b335b4-93d2-0459-e053-2a95a90a1a5b | 2025-12-26 | Warnings, Adverse reactions | 197379 |
| Atenolol | ATENOLOL | QPharma, Inc. | bd43e0b1-c05e-01ae-e053-2a95a90af1cd | 2025-12-19 | Boxed warning, Warnings, Adverse reactions | 197381 |
| Atenolol | ATENOLOL | QPharma, Inc. | 70d7a585-7a46-4eac-b2b5-2ac5b98d9882 | 2025-12-05 | Boxed warning, Warnings, Adverse reactions | 197381 |
| Atenolol | ATENOLOL | QPharma Inc | f682a775-2255-05e2-e053-2a95a90ac3f3 | 2025-12-03 | Warnings, Adverse reactions | 197381 |
| Atenolol | ATENOLOL | NuCare Pharmaceuticals,Inc. | 331128cc-f56e-4329-e063-6394a90a5ead | 2025-11-04 | Warnings, Adverse reactions | 197381 |
| Atenolol | ATENOLOL | NuCare Pharmaceuticals,Inc. | 410c48ae-582a-2ab2-e063-6294a90af27c | 2025-10-30 | Warnings, Adverse reactions | 197379 |
| Atenolol | ATENOLOL | PD-Rx Pharmaceuticals, Inc. | 95761173-1c95-46b2-a08f-fbc3e70daba8 | 2025-10-17 | Boxed warning, Warnings, Adverse reactions | 197380 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.